New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IQVIA Holdings Inc.
IQV
Shape
US Flag

NYSE

38B

Medical - Diagnostics & Research

Next Earning date - 01 May 2025

38B

Medical - Diagnostics & Research

Next Earning date - 01 May 2025

206.97USD

Shape-1.17 ( -0.56%)
Market Closed (as of Feb 10, 21:00 EDT)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

-47%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

21%

Quote Panel

Shape
Updated February 11, 2025
1W 0.74 % 1M 1.14 % 3M -3.09 % 1Y -5.01 %

Key Metrics

Shape
  • Market Cap

    37.57B


  • Shares Outstanding

    181.50M


  • Share in Float

    178.78M


  • Dividende

    0


  • Earning Date

    01 May 2025


  • Price Target

    206.97


  • Average Volume

    1.63M


  • Beta

    1.513


  • Range

    187.62-261.73


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.iqvia.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IQV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$16B

Shape303%

2025-Revenue

$11.92

Shape389%

2025-EPS

$3B

Shape203%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

BTIG

downgrade

Previous: Buy

2025-02-03

Now: Neutral

Stephens

initialise

Previous: Not converted

2024-12-19

Now: Overweight

RBC Capital

initialise

Previous: Outperform

2024-09-04

Now: Underperform

RBC Capital

initialise

Previous: Not converted

2024-09-03

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-1%

2.45
vs 2.47

Q2.23

arrow
arrow

0%

2.43
vs 2.44

Q3.23

arrow
arrow

+0%

2.49
vs 2.48

Q4.23

arrow
arrow

+2%

2.84
vs 2.78

Q1.24

arrow
arrow

+4%

2.54
vs 2.45

Q2.24

arrow
arrow

+9%

2.64
vs 2.43

Q3.24

arrow
arrow

+14%

2.84
vs 2.49

Q4.24

arrow
arrow

+10%

3.12
vs 2.84

Q1.25

arrow
arrow

+4%

2.63
vs 2.54

Q2.25

arrow
arrow

+7%

2.83
vs 2.64

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+2%

3.7B  vs 3.6B

Q2.23

arrow
arrow

+5%

3.7B  vs 3.5B

Q3.23

arrow
arrow

+5%

3.7B  vs 3.6B

Q4.23

arrow
arrow

+5%

3.9B  vs 3.7B

Q1.24

arrow
arrow

+2%

3.7B  vs 3.7B

Q2.24

arrow
arrow

+2%

3.8B  vs 3.7B

Q3.24

arrow
arrow

+4%

3.9B  vs 3.7B

Q4.24

arrow
arrow

+1%

4B  vs 3.9B

Q1.25

arrow
arrow

+1%

3.8B  vs 3.7B

Q2.25

arrow
arrow

+3%

3.9B  vs 3.8B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+5%

0.05
vs 0.04

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+5%

0.05
vs 0.05

Q4.23

arrow
arrow

+8%

0.08
vs 0.05

Q1.24

arrow
arrow

+5%

0.05
vs 0.08

Q2.24

arrow
arrow

+5%

0.05
vs 0.05

Q3.24

arrow
arrow

+4%

0.04
vs 0.05

Q4.24

arrow
arrow

+7%

0.07
vs 0.04

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

931

931
vs 894

4%

Q1.23

arrow
arrow

938

938
vs 931

1%

Q2.23

arrow
arrow

943

943
vs 938

1%

Q3.23

arrow
arrow

956

956
vs 943

1%

Q4.23

arrow
arrow

970

970
vs 956

1%

Q1.24

arrow
arrow

1029

1K
vs 970

6%

Q2.24

arrow
arrow

1028

1K
vs 1K

0%

Q3.24

arrow
arrow

1070

1.1K
vs 1K

4%

Earnings Growth

Latest News